Background. The aim of this retrospective study was to compare the long-term survival of patients receiving conservative with surgical treatment to analyze the prognostic factors and the impact of surgery on oncological outcomes of patients with primary gastric diffuse large B-cell lymphoma. Methods. A total of 2647 patients diagnosed with primary gastric diffuse large B-cell lymphoma from 1998 to 2014 were extracted from SEER database. Propensity matching was performed to compare the clinicopathological characteristics of the two groups. Based on the recursive partitioning analysis, the patients were divided into three risk subgroups: low risk, intermediate risk, and high risk. Results. After propensity score matching, patient characterist...
Objective. The purpose of this work is to compare the long-term survival between a control group wit...
Objective: to analyze the results of our series in order to assess whether surgical excision is stil...
Background: The optimal treatment of primary gastric large-cell non-Hodgkin’s lym-phoma (PGL) has no...
Treatment modalities for primary gastric diffuse large B-cell lymphoma (PG-DLBCL) have changed signi...
This study analyzes the value of surgery in the treatment, staging and long-term survival of 17 pati...
WOS: 000395632600034PubMed ID: 28263496Background/aim: Diffuse large B-cell primary gastric lymphoma...
BackgroundThe role of surgical resection in the treatment of primary gastric lymphoma (PGL) remains ...
PURPOSE: The use of surgery versus stomach-preserving treatment for primary gastric lymphoma has ca...
Background/Aims: Prirnary gastric lymphoma is an uncommom tumor, constituting less than 5% of gastri...
Abstract Management of localized primary gastric B lymphoma (PGL) remains controversial. The aim of ...
BACKGROUND: The definition of prognostic parameters in early stages of gastric lymphoma is still con...
Gastric cancer is one the most serious oncological pathologies and it occupies the third position in...
Gastric cancer keeps its position among the top five leaders of oncological mortality. Extended lymp...
I.F.: 0,490 Aims and background: The stomach is the most common site of primary extranodal non-Hodgk...
PurposeThe optimal treatment for primary gastric diffuse large B-cell lymphoma (PG-DLBCL) is still u...
Objective. The purpose of this work is to compare the long-term survival between a control group wit...
Objective: to analyze the results of our series in order to assess whether surgical excision is stil...
Background: The optimal treatment of primary gastric large-cell non-Hodgkin’s lym-phoma (PGL) has no...
Treatment modalities for primary gastric diffuse large B-cell lymphoma (PG-DLBCL) have changed signi...
This study analyzes the value of surgery in the treatment, staging and long-term survival of 17 pati...
WOS: 000395632600034PubMed ID: 28263496Background/aim: Diffuse large B-cell primary gastric lymphoma...
BackgroundThe role of surgical resection in the treatment of primary gastric lymphoma (PGL) remains ...
PURPOSE: The use of surgery versus stomach-preserving treatment for primary gastric lymphoma has ca...
Background/Aims: Prirnary gastric lymphoma is an uncommom tumor, constituting less than 5% of gastri...
Abstract Management of localized primary gastric B lymphoma (PGL) remains controversial. The aim of ...
BACKGROUND: The definition of prognostic parameters in early stages of gastric lymphoma is still con...
Gastric cancer is one the most serious oncological pathologies and it occupies the third position in...
Gastric cancer keeps its position among the top five leaders of oncological mortality. Extended lymp...
I.F.: 0,490 Aims and background: The stomach is the most common site of primary extranodal non-Hodgk...
PurposeThe optimal treatment for primary gastric diffuse large B-cell lymphoma (PG-DLBCL) is still u...
Objective. The purpose of this work is to compare the long-term survival between a control group wit...
Objective: to analyze the results of our series in order to assess whether surgical excision is stil...
Background: The optimal treatment of primary gastric large-cell non-Hodgkin’s lym-phoma (PGL) has no...